Discover key insights from the AAO 2025 meeting, highlighting advancements in real-world data, gene therapies, multitargeting treatments, and AI in retina care. Gene therapy revolutionizes retinal ...
The value of attending industry meetings at the beginning of a career in ophthalmology. Attending the American Academy of Ophthalmology (AAO) Annual Meeting for the first time can feel overwhelming.
Discover key insights from the AAO 2025 meeting, highlighting advancements in real-world data, gene therapies, multitargeting treatments, and AI in retina care. This year in retina is almost ...
Panelists discuss how real-world adherence to loading doses and thoughtful switching or reloading strategies can optimize durability and outcomes, particularly in undertreated patients. This segment ...
AI revolutionizes ophthalmology with enhanced diagnostics, personalized treatments, and improved surgical precision, offering better patient outcomes and efficient clinical trials. Artificial ...
The EU-ROP registry revolutionizes retinopathy of prematurity management, offering insights into treatment variations and outcomes across Europe. The management of retinopathy of prematurity (ROP) ...
Dr. Quan Dong Nguyen presents interim data from the phase 3 DRAGON study on a potential first therapy for adolescent Stargardt disease. Stargardt disease is a rare inherited retinal disorder that ...
Ocular Therapeutix announced it plans to accelerate its intended New Drug Application (NDA) for AXPAXLI (OTX-TKI) for the treatment of wet age-related macular degeneration (wet AMD) to the US Food and ...
During the 25th Congress of the European Society of Retina Specialists (EURETINA) held in Paris, France, in September 2025, the session “Macular Laser Treatment: Where Are We, Where Are We Going?” ...
New research highlights iron dysregulation's role in dry AMD, suggesting transferrin as a promising treatment to slow disease progression. A new study supports the hypothesis that iron dysregulation ...
Tode is a senior ophthalmologist and translational vision science researcher. He is deputy head of the Department at the Hannover Medical School in Germany and CEO of enVision Science UG. Tode’s ...
Explore the complexities of managing geographic atrophy in AMD patients, including treatment decisions and the importance of ongoing monitoring. Discover the latest insights on geographic atrophy, its ...